Plus Therapeutics, Inc.
PSTV
$5.50
-$0.03-0.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.58% | -29.17% | -185.87% | 129.60% | -345.84% |
| Total Depreciation and Amortization | -24.83% | 88.31% | 0.00% | -57.46% | -47.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 51.94% | 24.30% | 108.26% | -152.24% | 138,833.33% |
| Change in Net Operating Assets | 69.17% | -207.94% | 127.96% | -213.14% | -160.60% |
| Cash from Operations | 0.30% | -145.57% | 56.05% | 6.06% | -409.66% |
| Capital Expenditure | -2,626.67% | -11.11% | -285.71% | -133.33% | 72.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -100.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -636.87% | -179.08% | 128.63% | -230.98% | 4,608.00% |
| Cash from Investing | -692.29% | -183.04% | 128.00% | -230.19% | 5,459.38% |
| Total Debt Issued | 33.33% | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -- |
| Issuance of Common Stock | -- | -82.20% | 459.05% | -80.74% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1,062.59% | 79.16% | -1,970.00% | -- | -- |
| Cash from Financing | 222.33% | -77.22% | 340.16% | -77.46% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.59% | -140.98% | 244.83% | -177.97% | 953.62% |